Mick Burkhardt

946 total citations
13 papers, 780 citations indexed

About

Mick Burkhardt is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mick Burkhardt has authored 13 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mick Burkhardt's work include Peptidase Inhibition and Analysis (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cell Adhesion Molecules Research (2 papers). Mick Burkhardt is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cell Adhesion Molecules Research (2 papers). Mick Burkhardt collaborates with scholars based in Germany, India and China. Mick Burkhardt's co-authors include Glen Kristiansen, Manfred Dietel, Carsten Denkert, Tserenchunt Gansukh, Stefan Pahl, Klaus Jung, Anja Dankof, Monika Jung, Stefan A. Loening and Carsten Stephan and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and European Urology.

In The Last Decade

Mick Burkhardt

13 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mick Burkhardt Germany	11	421	293	215	107	102	13	780
Morihiro Higo Japan	18	584 1.4×	254 0.9×	228 1.1×	142 1.3×	65 0.6×	36	841
Ademi Santiago-Walker United States	13	402 1.0×	271 0.9×	190 0.9×	95 0.9×	120 1.2×	26	682
Melissa C Adriance United States	7	472 1.1×	380 1.3×	154 0.7×	91 0.9×	53 0.5×	7	805
Yukinao Kouzu Japan	18	541 1.3×	250 0.9×	189 0.9×	146 1.4×	53 0.5×	28	795
Rinat Keren United States	5	532 1.3×	327 1.1×	160 0.7×	141 1.3×	43 0.4×	5	763
Xavier Canron France	11	614 1.5×	285 1.0×	136 0.6×	117 1.1×	100 1.0×	12	879
Kei Matsuda United States	7	478 1.1×	305 1.0×	148 0.7×	226 2.1×	67 0.7×	13	687
Jenny Paupert Belgium	15	311 0.7×	313 1.1×	146 0.7×	63 0.6×	89 0.9×	23	683
Ivane Abiatari Georgia	13	460 1.1×	512 1.7×	214 1.0×	148 1.4×	164 1.6×	32	1.0k
Pak Shing Kwan Hong Kong	8	685 1.6×	439 1.5×	443 2.1×	91 0.9×	87 0.9×	10	1.0k

Countries citing papers authored by Mick Burkhardt

Since Specialization

Citations

This map shows the geographic impact of Mick Burkhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mick Burkhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mick Burkhardt more than expected).

Fields of papers citing papers by Mick Burkhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mick Burkhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mick Burkhardt. The network helps show where Mick Burkhardt may publish in the future.

Co-authorship network of co-authors of Mick Burkhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Mick Burkhardt. A scholar is included among the top collaborators of Mick Burkhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mick Burkhardt. Mick Burkhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Denkert, Carsten, Achilleas Thoma, Silvia Niesporek, et al.. (2007). Overexpression of cyclooxygenase‐2 in human prostate carcinoma and prostatic intraepithelial neoplasia‐association with increased expression of polo‐like kinase‐1. The Prostate. 67(4). 361–369. 19 indexed citations

Fritzsche, F., Edgar Dahl, Anja Dankof, et al.. (2007). Expression of AGR2 in non small cell lung cancer.. PubMed. 22(7). 703–8. 72 indexed citations

Gansukh, Tserenchunt, Carla A. Borgoño, Mick Burkhardt, et al.. (2006). Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status. British Journal of Cancer. 94(4). 540–547. 19 indexed citations

Rabien, Anja, Mick Burkhardt, Monika Jung, et al.. (2006). Decreased RECK Expression Indicating Proteolytic Imbalance in Prostate Cancer is Associated with Higher Tumor Aggressiveness and Risk of Prostate-Specific Antigen Relapse after Radical Prostatectomy. European Urology. 51(5). 1259–1266. 27 indexed citations

Burkhardt, Mick, Émpar Mayordomo, Tserenchunt Gansukh, et al.. (2006). Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. Journal of Clinical Pathology. 59(4). 403–409. 104 indexed citations

Fritzsche, Florian, Glen Kristiansen, Mick Burkhardt, et al.. (2006). Tissue Pretreatment With Formic Acid Might Lower HercepTest Scores in Breast Cancer. Diagnostic Molecular Pathology. 15(4). 237–242. 3 indexed citations

Staack, Andrea, Horst Schlechte, Markus D. Sachs, et al.. (2006). Clinical value of vesical leukoplakia and evaluation of the neoplastic risk by mutation analyses of the tumor suppressor gene TP53. International Journal of Urology. 13(8). 1092–1097. 9 indexed citations

Fritzsche, Florian, Stefan Pahl, Iver Petersen, et al.. (2006). Anaplastic large-cell non-Hodgkin’s lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer—a case report. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(5). 561–564. 49 indexed citations

Fritzsche, Florian, Edgar Dahl, Stefan Pahl, et al.. (2006). Prognostic Relevance of AGR2 Expression in Breast Cancer. Clinical Cancer Research. 12(6). 1728–1734. 96 indexed citations

10.

Jung, Monika, Chuanliang Xu, Carsten Stephan, et al.. (2005). Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?. Journal of Molecular Medicine. 83(12). 1014–1024. 187 indexed citations

11.

Weichert, Wilko, Carsten Denkert, Mick Burkhardt, et al.. (2005). Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival. Clinical Cancer Research. 11(18). 6574–6581. 144 indexed citations

12.

Xu, Chuanliang, Monika Jung, Mick Burkhardt, et al.. (2004). Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy. The Prostate. 62(3). 224–232. 40 indexed citations

13.

Bielenberg, Gerhard Wilhelm & Mick Burkhardt. (1990). 5-HT1A agonises show neuroprotectant activity in rats and mice. European Journal of Pharmacology. 183(5). 1953–1954. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact